Limited data exist regarding patient-reported outcomes and quality of life (QOL) experienced by patients with Barrett’s esophagus (BE) referred for endoscopic eradication therapy (EET).
https://academic.oup.com/dote/advance-article-abstract/doi/10.1093/dote/doy086/5085984?redirectedFrom=fulltext
Dysplasia severity is associated with poor quality of life in patients with Barrett's esophagus referred for endoscopic eradication therapy